Bridging data and drug development: Machine learning approaches for next-generation ADMET prediction

Area of Science:

• Computational chemistry and pharmacology
• Drug discovery and development
• Artificial intelligence in medicine

Background:

• Absorption, distribution, metabolism, excretion, and toxicity (ADMET) evaluation is critical for drug candidate success.
• Traditional experimental ADMET methods are reliable but resource-intensive.
• Existing computational models often lack robustness and generalizability for ADMET prediction.

Purpose of the Study:

• To systematically review state-of-the-art machine learning (ML) methodologies for ADMET prediction.
• To explore emerging strategies for enhancing the accuracy and translational relevance of computational ADMET models.
• To highlight the role of AI in improving drug discovery and development processes.

Main Methods:

• Examination of advanced ML techniques, including graph neural networks, ensemble learning, and multitask frameworks.
• Analysis of emerging strategies for multimodal data integration.
• Review of algorithmic optimization techniques for predictive performance.

Main Results:

• ML models demonstrate significant potential in deciphering complex structure-property relationships for ADMET prediction.
• Advanced ML approaches offer scalable and efficient alternatives to traditional experimental and computational methods.
• The integration of multimodal data and optimized algorithms enhances predictive accuracy.

Conclusions:

• ML-driven ADMET prediction is transforming drug discovery by providing robust and generalizable computational tools.
• These methods help mitigate late-stage attrition and support preclinical decision-making.
• AI-powered ADMET prediction accelerates the development of safer and more effective therapeutics.